m4011972

Given the Economist's endorsement of Abenomics style inflationary action by the ECB, do you think such action, in tandem with Japan would put pressure on the Fed to delay its tapering in an effort to avoid rapidly strengthening the dollar in comparison to both the Yen and Euro simultaneously, potentially harmful to the US balance of trade?

Given the public's concern over the largely behind-closed-doors negotiation of trade deals such as CETA and TTIP, what can governments and organisations in favour of trade liberalisation do to better sell the idea to sceptical populaces more easily swayed by impassioned protectionist arguments?

How should America balance its obligations to protect its constituent pharmaceutical companies legacy of invest and innovation through patent law and protection of Intellectual Property with the fact that in most of the developing world, the major medical problems require greater access to existing medicines and treatment regimens, not the invention of novel medicines, which IPR protection is designed to encourage?